l-Carnitine effects on bioenergetics and H2O2 emission rates of skeletal muscle and liver mitochondria. l-Carnitine (2 mm; Carn) was utilized to decrease levels of long-chain fatty acid catabolic intermediates within the mitochondrial matrix. Mitochondria (0.2 mg/ml) were supplied with 18 μm PCarn. A, in mitochondria supplied with PCarn plus [1-14C]palmitoylcarnitine, the [14C]acid-soluble product (14C-ASP) was used as a measure of LCFA catabolic intermediate levels within the matrix (pellet) and effluxed from mitochondria into the buffer (buffer). Above the bar in the muscle panel, a and b, p < 0.003 and p < 0.015 for buffer and pellet fractions, respectively, paired t test, without l-carnitine versus with l-carnitine. Above the bar in the liver panel, #, p = 0.08, paired t test, [14C]ASP was increased in the buffer fraction in four of four preparations. B, rate of 14CO2 production. C–F, bioenergetic parameters (C and D) and H2O2 emission rates (E and F) were determined under the same conditions as in A and B, using only cold PCarn. In F, CDNB was used to deplete mitochondria of reduced glutathione. A–D, n = 4; E and F, n = 7–8. In all panels, values are means ± S.E. * and ***, p < 0.05 and p < 0.005, respectively, paired t test.